Pre-made Technetium (99Mtc) Pintumomab benchmark antibody (Radiolabelled antibody, anti-human adenocarcinoma antigen therapeutic antibody) for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Anti-human adenocarcinoma antigen therapeutic antibody (Pre-made Technetium (99Mtc)
Pintumomab biosimilar, Radiolabelled antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Technetium (99mTc) pintumomab (INN) is a mouse monoclonal antibody for the imaging of adenocarcinoma. It is labelled with the radioisotope technetium-99m.[1]
| Products Name (INN Index) | Pre-Made Technetium (99Mtc) Pintumomab Biosimilar, Radiolabelled Antibody: Anti-Human Adenocarcinoma Antigen therapeutic antibody |
|---|---|
| INN Name | technetium (99mTc) pintumomab |
| Target | human adenocarcinoma antigen |
| Format | Radiolabelled antibody |
| Derivation | Mus musculus |
| Species Reactivity | Human |
| CH1 Isotype | IgG1 – kappa |
| VD LC | IgG1 – kappa |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | NA |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | human adenocarcinoma antigen |
| Package |
